Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Shares Outstanding (2016 - 2025)

Utah Medical Products (UTMD) has 16 years of Shares Outstanding data on record, last reported at $3.2 million in Q3 2025.

  • For Q3 2025, Shares Outstanding fell 6.89% year-over-year to $3.2 million; the TTM value through Sep 2025 reached $3.2 million, down 6.89%, while the annual FY2024 figure was $3.3 million, 8.13% down from the prior year.
  • Shares Outstanding reached $3.2 million in Q3 2025 per UTMD's latest filing, roughly flat from $3.2 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $3.7 million in Q4 2021 and bottomed at $3.2 million in Q3 2025.
  • Average Shares Outstanding over 5 years is $3.5 million, with a median of $3.6 million recorded in 2022.
  • Peak YoY movement for Shares Outstanding: rose 0.33% in 2021, then dropped 8.56% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $3.7 million in 2021, then fell by 0.74% to $3.6 million in 2022, then grew by 0.06% to $3.6 million in 2023, then dropped by 8.13% to $3.3 million in 2024, then dropped by 3.93% to $3.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $3.2 million in Q3 2025, $3.2 million in Q2 2025, and $3.3 million in Q1 2025.